Testotoxicosis proved by immunohistochemical analysis and successfully treated with cyproterone acetate

Urologia Internationalis

Volumn 57, Issue 3, 1996, Pages 199-202

  Itoh, Keiichi ^a   Nakada, Teruhiro ^a   Kubota, Yoko ^a   Suzuki, Hitoshi ^a   Ishigooka, Manabu ^a   Izumi, Takuji ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Cyproterone acetate; Cyproterone acetate treatment; Precocious puberty; Precocious puberty (testotoxicosis); Testotoxicosis

Indexed keywords

ANTIANDROGEN; CYPROTERONE ACETATE; TESTOSTERONE;

ARTICLE; CASE REPORT; DRUG EFFICACY; HUMAN; IMMUNOHISTOCHEMISTRY; LEYDIG CELL; MALE; PRECOCIOUS PUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; TESTIS; TESTIS BIOPSY; TESTOSTERONE BLOOD LEVEL;

EID: 0029819067     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000282913     Document Type: Article

References (17)

1. Kaplan SL, Grumbach MM: Pathophysiology and treatment of sexual precocity. J Clin Endocrinol Metab 1990:71:785-789.
2. Holland FJ: Gonadotropin-independent precocious puberty. Endocrinol Metab Clin North Am 1991:20:191-210.
3. Grumbach MM, Kaplan SL: Recent advances in the diagnosis and management of sexual precocity. Acta Paediatr Jpn 1988:30(suppl): 155-175.
4. Grumbach MM, Kaplan SL: The neuroendocrinology of human puberty: An ontogcnic perspective: in Grumbach MM. Sizonenko PC. Aubert ML (eds): Control of the Onset of Puberty. Baltimore, Williams & Wilkins. 1990. pp 1-68.
5. Rosenthal SM, Grumbach MM, Kaplan SL: Gonadotropin-independent familial sexual precocity with premature Levdig and germinal cell maturation (familial testotoxicosis): Effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases. J Clin Endocrinol Metab 1983:57:571-579.
6. Holland FJ, Kirsch SE, Selby R: Gonadotropin-independent precocious puberty (‘testotoxicosis’): Influence of maturational status on response to ketoconazole. J Clin Endocrinol Metab 1987:64:328-333.
7. Marshall WA, Tanner JM: Various in the pattern of pubertal changes in boys. Arch Dis Child 1970:45:13.
8. Greulich WW, Pyle SL: Radiographic Skeletal Development of the Hand and Wrist. Stanford. Stanford University Press. 1959.
9. Schedcwie HK, Reiter EO, Beilins IZ, Scycd S, Wooten VD, Jimenez JF, Aiman EJ, Dc Vane GW, Redman JF, Elders MJ: Testicular Lcydig cell hyperplasia as a cause of familial sexual precocity. J Clin Endocrinol Metab 1981:52: 271-278.
10. Egli CA, Rosenthal SM, Grumbach MM, Montalvo JM, Gondos B: Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations: Familial testotoxicosis. J Pcdiatr 1985:106:33-40.
11. Gondos B, Egli CA, Rosenthal SM, Grumbach MM: Testicular changes in gonadotropin-independent familial male sexual precocity. Arch Pathol Lab Med 1985:109:990-995.
12. Grumbach MM, Roth JC, Kaplan SL, Kelch RP: Hypothalamic-pituitary regulation of puberty in man: Evidence and concepts derived from clinical research: in Grumbach MM. Grave GD. Mayer FE (eds): The Control of the Onset of Puberty. New York. Wiley & Sons. 1974. p 115.
13. Grumbach MM: The neurocndocrinology of puberty: in Krieger DT, Hughes JC (eds): Ncu-rocndocrinology. Sunderland. Sinauer. 1980. p 249.
14. Wicrman ME, Bcardsworth DE, Mansfield MJ, Badger TM, Crawford JD, Crigler JF, Bode HH, Loughlin JS, Kushner DC, Scully RE, Hoffman WH, Crowley WF: Puberty without gonadotropins: A unique mechanism of sexual development. N F.ngl J Med 1985:312: 65-72.
15. Holland FJ, Fishman L, Bailey JD, Fazckas ATA: Ketoconazole in the management of precocious puberty not responsive to LHRH-ana-loguc therapy. N Engl J Med 1985:312:1023-1028.
16. Laue L, Jones J, Barnes KM, Cutler GB: Treatment of familial male precocious puberty w ith spironolactone, testolactone and dcslorclin. J Clin Endocrinol Metab 1993:76:151-155.
17. Lorini R, Colombo A, Ugazio AG, et al: Cypro-terone acetate treatment in precocious puberty. J Endocrinol Invest 1981 -.4:263-269.